Mink Therapeutics Inc (INKT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.95M
Last updated: Nov 17, 2026 at 11:05 AM ET
Mink Therapeutics Inc (INKT) Stock Forecast
Analysts expect Mink Therapeutics (INKT) to earn -$2.45 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.72.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$2.45
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.72
- EPS consensus
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$2.45 | -$2.58 to -$2.32 | 2 |
| Dec 31, 2027 | -$0.72 | -$0.72 to -$0.72 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.52 | -$0.62 to -$0.41 | 4 | $1.05M | $245000 to $1.89M | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.46.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.45 | -$2.53 | -$1.93 | -$1.93 | -$2.46 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.72 | -$1.57 | -$1.97 | -$2.65 | -$2.86 | N/A |
Frequently Asked Questions About INKT
What is the INKT stock forecast?
Consensus analyst estimates put Mink Therapeutics's EPS at -$2.45 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from INKT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.45, with estimates from -$2.58 to -$2.32 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.72, with estimates from -$0.72 to -$0.72 from 1 analyst.
How many analysts cover INKT?
2 analysts estimate EPS for Mink Therapeutics for the fiscal year ending Dec 31, 2026.
INKT pages: Overview, Earnings, Forecast, Financials, Competitors